| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Department of Molecular Genetics,*
Hellenic
Pasteur Institute, Athens, Greece; and the Department of Experimental
Neuropathology,
Institute of Neurology,
University of Vienna, Vienna, Austria
The scientific dogma that multiple sclerosis (MS) is a disease caused by a single pathogenic mechanism has been challenged recently by the heterogeneity observed in MS lesions and the realization that not all patterns of demyelination can be modeled by autoimmune-triggered mechanisms. To evaluate the contribution of local tumor necrosis factor (TNF) ligand/receptor signaling pathways to MS immunopathogenesis we have analyzed disease pathology in central nervous system-expressing TNF transgenic mice, with or without p55 or p75TNF receptors, using combined in situ terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling and cell identification techniques. We demonstrate that local production of TNF by central nervous system glia potently and selectively induces oligodendrocyte apoptosis and myelin vacuolation in the context of an intact blood-brain barrier and absence of immune cell infiltration into the central nervous system parenchyma. Interestingly, primary demyelination then develops in a classical manner in the presence of large numbers of recruited phagocytic macrophages, possibly the result of concomitant pro-inflammatory effects of TNF in the central nervous system, and lesions progress into acute or chronic MS-type plaques with axonal damage, focal blood-brain barrier disruption, and considerable oligodendrocyte loss. Both the cytotoxic and inflammatory effects of TNF were abrogated in mice genetically deficient for the p55TNF receptor demonstrating a dominant role for p55TNF receptor-signaling pathways in TNF-mediated pathology. These results demonstrate that aberrant local TNF/p55TNF receptor signaling in the central nervous system can have a potentially major role in the aetiopathogenesis of MS demyelination, particularly in MS subtypes in which oligodendrocyte death is a primary pathological feature, and provide new models for studying the basic mechanisms underlying oligodendrocyte and myelin loss.
This article has been cited by other articles:
 |
|
 |
|
  R. Covacu, L. Arvidsson, A. Andersson, M. Khademi, H. Erlandsson-Harris, R. A. Harris, M. A. Svensson, T. Olsson, and L. Brundin TLR Activation Induces TNF-{alpha} Production from Adult Neural Stem/Progenitor Cells J. Immunol., June 1, 2009; 182(11): 6889 - 6895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Musse, Z. Li, C. A. Ackerley, D. Bienzle, H. Lei, R. Poma, G. Harauz, M. A. Moscarello, and F. G. Mastronardi Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system Dis. Model. Mech., November 1, 2008; 1(4-5): 229 - 240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Li, E. R. Ramenaden, J. Peng, H. Koito, J. J. Volpe, and P. A. Rosenberg Tumor Necrosis Factor {alpha} Mediates Lipopolysaccharide-Induced Microglial Toxicity to Developing Oligodendrocytes When Astrocytes Are Present J. Neurosci., May 14, 2008; 28(20): 5321 - 5330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Adams, J. Bauer, M. J. Flick, S. L. Sikorski, T. Nuriel, H. Lassmann, J. L. Degen, and K. Akassoglou The fibrin-derived {gamma}377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease J. Exp. Med., March 19, 2007; 204(3): 571 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Touil, D. Fitzgerald, G.-X. Zhang, A. Rostami, and B. Gran Cutting Edge: TLR3 Stimulation Suppresses Experimental Autoimmune Encephalomyelitis by Inducing Endogenous IFN-beta J. Immunol., December 1, 2006; 177(11): 7505 - 7509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. G. Mastronardi, D. D. Wood, J. Mei, R. Raijmakers, V. Tseveleki, H.-M. Dosch, L. Probert, P. Casaccia-Bonnefil, and M. A. Moscarello Increased Citrullination of Histone H3 in Multiple Sclerosis Brain and Animal Models of Demyelination: A Role for Tumor Necrosis Factor-Induced Peptidylarginine Deiminase 4 Translocation. J. Neurosci., November 1, 2006; 26(44): 11387 - 11396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M H Barnett, A P. Henderson, and J W Prineas The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion Multiple Sclerosis, April 1, 2006; 12(2): 121 - 132. [Abstract] [PDF]
|
|
|
|
|
|
R P Lisak, J A Benjamins, B Bealmear, B Yao, S Land, L Nedelkoska, and D Skundric Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures Multiple Sclerosis, April 1, 2006; 12(2): 149 - 168. [Abstract] [PDF]
|
|
|
|
|
|
A. S. Paintlia, M. K. Paintlia, I. Singh, and A. K. Singh IL-4-Induced Peroxisome Proliferator-Activated Receptor {gamma} Activation Inhibits NF-{kappa}B Trans Activation in Central Nervous System (CNS) Glial Cells and Protects Oligodendrocyte Progenitors under Neuroinflammatory Disease Conditions: Implication for CNS-Demyelinating Diseases J. Immunol., April 1, 2006; 176(7): 4385 - 4398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Gimenez, J. Sim, A. S. Archambault, R. S. Klein, and J. H. Russell A Tumor Necrosis Factor Receptor 1-Dependent Conversation between Central Nervous System-Specific T Cells and the Central Nervous System Is Required for Inflammatory Infiltration of the Spinal Cord Am. J. Pathol., April 1, 2006; 168(4): 1200 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Jeffery Use of combination therapy with immunomodulators and immunosuppressants in treating multiple sclerosis Neurology, December 28, 2004; 63(12_suppl_6): S41 - S46. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Marchetti, M. Klein, K. Schlett, K. Pfizenmaier, and U. L. M. Eisel Tumor Necrosis Factor (TNF)-mediated Neuroprotection against Glutamate-induced Excitotoxicity Is Enhanced by N-Methyl-D-aspartate Receptor Activation: ESSENTIAL ROLE OF A TNF RECEPTOR 2-MEDIATED PHOSPHATIDYLINOSITOL 3-KINASE-DEPENDENT NF-{kappa}B PATHWAY J. Biol. Chem., July 30, 2004; 279(31): 32869 - 32881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Adams, M. Passino, B. D. Sachs, T. Nuriel, and K. Akassoglou Fibrin Mechanisms and Functions in Nervous System Pathology Mol. Interv., June 1, 2004; 4(3): 163 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Niculescu, S. Weerth, F. Niculescu, C. Cudrici, V. Rus, C. S. Raine, M. L. Shin, and H. Rus Effects of Complement C5 on Apoptosis in Experimental Autoimmune Encephalomyelitis J. Immunol., May 1, 2004; 172(9): 5702 - 5706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Akassoglou, R. A. Adams, J. Bauer, P. Mercado, V. Tseveleki, H. Lassmann, L. Probert, and S. Strickland Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis PNAS, April 27, 2004; 101(17): 6698 - 6703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. B. Jones, D. P. Ankeny, Z. Guan, V. McGaughy, L. C. Fisher, D. M. Basso, and P. G. Popovich Passive or Active Immunization with Myelin Basic Protein Impairs Neurological Function and Exacerbates Neuropathology after Spinal Cord Injury in Rats J. Neurosci., April 14, 2004; 24(15): 3752 - 3761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Akassoglou, B. Malester, J. Xu, L. Tessarollo, J. Rosenbluth, and M. V. Chao Brain-specific deletion of neuropathy target esterase/swisscheese results in neurodegeneration PNAS, April 6, 2004; 101(14): 5075 - 5080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas Theiler's Virus Infection: a Model for Multiple Sclerosis Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Jolicoeur, C. Hu, T. W. Mak, J.-C. Martinou, and D. G. Kay Protection against Murine Leukemia Virus-Induced Spongiform Myeloencephalopathy in Mice Overexpressing Bcl-2 but Not in Mice Deficient for Interleukin-6, Inducible Nitric Oxide Synthetase, ICE, Fas, Fas Ligand, or TNF-R1 Genes J. Virol., December 15, 2003; 77(24): 13161 - 13170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Bradl and R Hohlfeld Molecular pathogenesis of neuroinflammation J. Neurol. Neurosurg. Psychiatry, October 1, 2003; 74(10): 1364 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Akassoglou, E. Douni, J. Bauer, H. Lassmann, G. Kollias, and L. Probert Exclusive tumor necrosis factor (TNF) signaling by the p75TNF receptor triggers inflammatory ischemia in the CNS of transgenic mice PNAS, January 21, 2003; 100(2): 709 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Yang, K. Lindholm, Y. Konishi, R. Li, and Y. Shen Target Depletion of Distinct Tumor Necrosis Factor Receptor Subtypes Reveals Hippocampal Neuron Death and Survival through Different Signal Transduction Pathways J. Neurosci., April 15, 2002; 22(8): 3025 - 3032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-C. Chen, M. W. Leach, Y. Chen, X.-Y. Cai, L. Sullivan, M. Wiekowski, B. J. Dovey-Hartman, A. Zlotnik, and S. A. Lira Central Nervous System Inflammation and Neurological Disease in Transgenic Mice Expressing the CC Chemokine CCL21 in Oligodendrocytes J. Immunol., February 1, 2002; 168(3): 1009 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Daigle, J.-H. Hong, C.-S. Chiang, and W. H. McBride The Role of Tumor Necrosis Factor Signaling Pathways in the Response of Murine Brain to Irradiation Cancer Res., December 1, 2001; 61(24): 8859 - 8865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kornek, M. K. Storch, J. Bauer, A. Djamshidian, R. Weissert, E. Wallstroem, A. Stefferl, F. Zimprich, T. Olsson, C. Linington, et al. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis Brain, June 1, 2001; 124(6): 1114 - 1124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Kassiotis and G. Kollias Uncoupling the Proinflammatory from the Immunosuppressive Properties of Tumor Necrosis Factor (Tnf) at the P55 TNF Receptor Level: Implications for Pathogenesis and Therapy of Autoimmune Demyelination J. Exp. Med., February 19, 2001; 193(4): 427 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Weishaupt, S. Jander, W. Bruck, T. Kuhlmann, M. Stienekemeier, T. Hartung, K. V. Toyka, G. Stoll, and R. Gold Molecular Mechanisms of High-Dose Antigen Therapy in Experimental Autoimmune Encephalomyelitis: Rapid Induction of Th1-Type Cytokines and Inducible Nitric Oxide Synthase J. Immunol., December 15, 2000; 165(12): 7157 - 7163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Jin, D. P. Raymond, T. D. Crabtree, S. J. Pelletier, C. W. Houlgrave, T. L. Pruett, and R. G. Sawyer Enhanced Murine Macrophage TNF Receptor Shedding by Cytosine-Guanine Sequences in Oligodeoxynucleotides J. Immunol., November 1, 2000; 165(9): 5153 - 5160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-X. Huang, P. Huang, A. Gomes, and J. Hillert Apoptosis mediators FasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS Neurology, October 10, 2000; 55(7): 928 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Probert, H.-P. Eugster, K. Akassoglou, J. Bauer, K. Frei, H. Lassmann, and A. Fontana TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease Brain, October 1, 2000; 123(10): 2005 - 2019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Xaus, M. Comalada, A. F. Valledor, J. Lloberas, F. Lopez-Soriano, J. M. Argiles, C. Bogdan, and A. Celada LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-alpha Blood, June 15, 2000; 95(12): 3823 - 3831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Akassoglou, K. W. Kombrinck, J. L. Degen, and S. Strickland Tissue Plasminogen Activator-Mediated Fibrinolysis Protects against Axonal Degeneration and Demyelination after Sciatic Nerve Injury J. Cell Biol., May 29, 2000; 149(5): 1157 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-K. Kim, Y. Kan, D. Ganea, R. P. Hart, I. Gozes, and G. M. Jonakait Vasoactive Intestinal Peptide and Pituitary Adenylyl Cyclase-Activating Polypeptide Inhibit Tumor Necrosis Factor-alpha Production in Injured Spinal Cord and in Activated Microglia via a cAMP-Dependent Pathway J. Neurosci., May 15, 2000; 20(10): 3622 - 3630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Delaney and E. L. Feldman Review {blacksquare} : Insulin-like Growth Factor-I and Apoptosis in Glial Cell Biology Neuroscientist, February 1, 2000; 6(1): 39 - 47. [Abstract] [PDF]
|
|
|
|
|
|
L. Soane, H. Rus, F. Niculescu, and M. L. Shin Inhibition of Oligodendrocyte Apoptosis by Sublytic C5b-9 Is Associated with Enhanced Synthesis of Bcl-2 and Mediated by Inhibition of Caspase-3 Activation J. Immunol., December 1, 1999; 163(11): 6132 - 6138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ye and A. J. D’Ercole Insulin-Like Growth Factor I Protects Oligodendrocytes from Tumor Necrosis Factor-{alpha}-Induced Injury Endocrinology, July 1, 1999; 140(7): 3063 - 3072. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Rogove, C Siao, B Keyt, S Strickland, and S. Tsirka Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system J. Cell Sci., January 11, 1999; 112(22): 4007 - 4016. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
